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Abstract 
 
Background 
 
Palliative care has been highlighted as an urgent need for patients with both 
HIV/AIDS and cancer in sub-Saharan Africa. Morphine is considered by the 
WHO as the drug of choice for severe pain in cancer. Pain is common in people 
with HIV/AIDS, though it is frequently unrecognised or poorly treated. Health 
workers fears about morphine have been reported to be a barrier to patients’ 
accessing necessary pain medication in studies from Africa as well as other 
parts of the world.   
 
Methods 
 
Semi-structured interviews were conducted with a total of fifteen nurses, 
clinicians, health service managers and pharmacy staff at five sites in the 
Southern Region of Malawi between November 2007 and February 2008. 
Study sites were randomly selected from groupings representing the different 
hospital institutions which exist in the region (district and central government 
institutions and mission hospitals). Interviews were conducted in either English 
or Chichewa. After translation, interview data was intensively reviewed by the 
researcher and emerging themes were identified. 
 
Results 
 
Three main themes were identified during the interviews. Firstly the availability 
of oral morphine, secondly concerns about opiate misuse  and thirdly the need 
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for education and training amongst health workers and community members. 
Respondents understood that morphine was a strong pain killer, which they 
thought was useful and should be more widely available for patients with both 
HIV/AIDS and cancer related problems, though reported stock outs at their 
institutions were common. Oral morphine was available at only two of the 
institutions visited at the time of the interviews. A third of respondents were 
unable to supply information on correct practises for storage and reporting of 
morphine. Concerns were expressed about making oral morphine available to 
patients at home. Fears about addiction (either amongst patients or health 
workers) directly affected their prescribing practise, as respondents reported 
that they may either prescribe lower doses or only prescribe morphine late in 
the course of the illness to try to reduce the risk of addiction.  
 
Conclusions and recommendations 
 
Many of the health workers requested improved availability of oral morphine to 
treat patients with HIV/AIDS and cancer with severe pain. However other 
beliefs, attitudes and practises of health workers in the Southern Region of 
Malawi present major barriers to timely access to oral morphine for patients in 
need. Further education, training and hands on experience are required for 
health care workers (including pharmacy staff). Advocacy should be intensified 
at national and international level towards the development of appropriate 
policies and supply chains to improve the availability of morphine for medical 
purposes.  
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Introduction 
 
“The medical use of narcotic drugs continues to be indispensable 
for the relief of pain and suffering and adequate provision must be 
made to ensure the availability of narcotic drugs for such purposes’’1 
 
The above quote is taken from the United Nations Single Convention on 
Narcotic drugs which was adopted internationally in 1961 to ensure the safe 
and appropriate use of narcotic drugs. So why - almost half a century after such 
endorsements - should a recent press release state that ‘Africans die in pain 
because of fears of opiate addiction’?2 
 
Palliative care has been highlighted as an urgent need for patients with both 
HIV/AIDS and cancer in sub-Saharan Africa3 4. More recently palliative care 
has been put forward as a basic human right5 6.  Central to the WHO definition 
of palliative care is the ‘early identification and impeccable assessment and 
treatment of pain…’7.  Morphine is recommended by the WHO as the drug of 
choice for severe pain in cancer. The WHO analgesic ladder, which was initially 
developed in the 1980s, has been shown to control pain in over seventy five 
per cent of patients with cancer8. These guidelines have now been 
recommended for pain management in other conditions including HIV/AIDS9.  
The production, processing and distribution of morphine is carefully controlled 
and regulated by the International Narcotics Control Board in collaboration with 
national governments in order to minimise the risk of diversion for use by drug 
addicts.  A survey of palliative care users of oral morphine in India found no 
instances of misuse or diversion of opiates, despite the fears of the 
authorities10.  The INCB, the World Health Assembly and other international 
bodies have noted that, whilst stringent controls are adhered to, the obligation 
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to promote access to opiates for medical purposes is often neglected.  The 
Pain and Policy Studies Group (a WHO Collaborating Centre) was founded in 
1996 with the aim of promoting appropriate availability of opioid analgesics for 
medical purposes11, resulting in the WHO guidelines entitled ‘Achieving 
Balance in National Opioids Control Policy’ to help governments address 
relevant issues. 
 
 In 2002 it was estimated that around 24.6 million people were living with 
cancer around the globe, and 10.9 million new cases were diagnosed. Around 
6.7 million people died from cancer in that year12. It is estimated that between 
eighty eight and ninety five percent of patients with cancer in Africa present at a 
late or end stage of disease13, with trends suggesting that cancer incidence is 
rising rapidly. The London declaration on Cancer Control in Africa in 2007 
stated that ‘African countries will account for over a million cases of cancer per 
year’14 whilst resource and infrastructure challenges limit an appropriate 
response to this burden of disease.  
 
Globally there were over 38 million people living with HIV at the end of 2005 
and an estimated 2.8 million died of AIDS15.  Pain occurs in adults and children 
with HIV as a result of a variety of factors: from HIV itself, from opportunistic 
infections and as a result of the side effects of ARV medication. As Grey and 
Berger wrote in a recent review article: ‘despite a high prevalence of pain 
associated with HIV disease, pain is usually under-diagnosed and poorly 
treated’16 . The WHO has stated that palliative care is ‘an essential component 
of a comprehensive package of care for people living with HIV/AIDS as an 
important means of relieving symptoms that result in undue suffering and 
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frequent visits to the hospital or clinic’17.  Some may argue that as access to 
ARV therapy is improving, palliative care is no longer required.  Clinical 
experience and research suggest otherwise, with a study in Tanzania reporting 
that over fifty percent of seven hundred and thirty one patients presenting for 
HIV care had palliative care needs, and this in a setting where ARV therapy 
was readily available18.   
   
There is now over four decades of clinical expertise and research in the modern 
hospice and palliative care movement, as well as increasing advocacy 
supported by a host of international agreements and research evidence.  
Despite all of this, statistics from the International Narcotics Control Board show 
that developing countries - with eighty percent of the world’s population - 
consume only six percent of the world’s supply of morphine19. In Africa 
advocacy for availability of pain relieving drugs has accelerated under the 
leadership of the African Palliative Care Association with the backing of several 
high profile international donors.  As part of these advocacy efforts, APCA has 
hosted a series of regional drug availability workshops across the continent with 
country teams taking on the task of implementing the workplans they 
developed. 
 
Malawi is a very low income country in Sub-Saharan Africa suffering under the 
combined effects of the HIV/AIDS epidemic and poverty, ranking 164 out of 177 
on the Human Development index20. Seventy six percent of the total population 
live on less than two dollars per day15,life expectancy is forty seven years21, 
and only seven percent of households have electricity22.  Twelve percent of 15-
49 year olds in a total population of around thirteen and a half million are 
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infected with HIV, and around sixty one thousand deaths per year are 
attributable to AIDS23.  There are multiple pressing priorities for limited health 
resources – under-five mortality was one hundred and thirty three per thousand 
live births between 2000-200422 and the population suffers an estimated six 
million episodes of malaria annually24. One hundred thousand adults and 
children are currently on antiretroviral therapy, with an ambitious goal to have 
started two hundred and fourty five thousand patients by 201023.  
Two thirds of health services in Malawi are government facilities (central 
hospitals in the four major cities, district hospitals in other towns, plus related 
health centres) under the Ministry of Health. The Christian Health Association 
of Malawi (CHAM) provides a further one quarter of all health services (mission 
hospitals and related health centres), with a variety of non-government 
organisations and private sector services operating sporadically25. Fifty four 
percent of the population live more than five kilometres from their nearest 
health facility.26  
Malawi is split into three regions: north, central and south, with the highest 
population density and HIV rates in the southern region27.  Palliative care has 
been introduced over the last seven years, and there is increasing awareness 
of the benefits of providing good pain and symptom control for those with life 
threatening illnesses.  At the regional drug availability workshop hosted by 
APCA in June 2006, a high level delegation from Malawi identified three key 
areas affecting morphine supply.  Firstly the poor supply of liquid morphine, 
secondly poor data collection and reporting systems by health facilities and 
thirdly patients’ limited accessibility to morphine.  The attitudes, beliefs and 
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practise of health care workers play a critical role in these last two areas. 
Investigation of these forms the basis of this study. 
In Malawi, morphine is listed as a high priority, vital drug in the Essential Health 
Package Medicines and Supplies list25. Between 1990 and 2007, the INCB 
received only one annual report on morphine use from Malawi28. Following the 
inclusion of a chapter on palliative care in the Ministry of Health guidelines 
‘Management of HIV related Diseases’ in 2004, morphine (as MST 10 mg 
tablets) has been supplied free of charge to all hospitals in Malawi which deliver 
antiretroviral drugs as part of a package of care and support funded through the 
Global Fund. Stocks and supplies of MST have been recorded quarterly at all 
hospital sites delivering antiretroviral treatment by supervision teams from the 
Ministry of Health HIV unit.  National supply of MST has been out of stock from 
2006 and – due to lack of adequate routine reporting to the INCB – further 
morphine could not be imported in 2007 as the national import quota ceiling 
had been reached.  Oral morphine solution (an alternative and cheaper 
preparation of morphine) has also been available through the Lighthouse Trust 
in Lilongwe for use at a limited number of sites where palliative care teams 
have developed.  Reporting to the INCB has been restarted as of 2007, with the 
Ministry of Health handing over its responsibility as the national statutory body 
to the Pharmacy, Medicines and Poisons Board (PMPB). As a result of 
completed returns and at the request of the PMPB the quota for morphine has 
recently been increased.  
The Palliative Care Association of Malawi was registered in 2006.  It has been 
working in partnership with the Ministry of Health to promote, develop and 
support access to affordable and culturally appropriate palliative care through 
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advocacy, training and technical support. As a result, a five day introductory 
training course for health care workers has been established.  Around five 
hundred people have completed this training which includes modules on pain 
assessment, pain management, and the safe and appropriate use of morphine.  
However, there is as yet no official government policy relating to the provision 
of palliative care and a number of senior health advisors lack awareness on 
issues relating to palliative care. 
Countrywide all health services are delivered against a background of a critical 
shortage of human resources, with 55% of nursing posts and 59% of posts for 
medical staff in Ministry of Health and CHAM facilities standing vacant last 
year29.  There is a higher concentration of the limited number of skilled staff 
working in urban central hospitals.  A report in 2003 found that less than ten 
percent of hospitals had the capacity to deliver the Essential Health Package 
(comprising eleven key components of health care which should be available to 
all Malawians)25.  One of the main aims of the 2004-2010 government health 
plan is to increase human resource capacity, and this is being supported 
through the donor-funded Emergency Human Resource Programme.  
Enrolment of clinical officers has doubled and of medical students has tripled 
under this programme. In order to scale up access to morphine much of the 
work will- by necessity -have to be integrated into the daily workload of all 
clinical staff, rather than being delegated to dedicated palliative care teams. 
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 Literature review 
As long ago as 1986 the World Health Organisation produced guidelines for the 
safe and effective control of cancer related pain30.  Two years later Stjernsward 
reported field tests that showed use of these guidelines resulted in effective 
pain relief in over 80% of patients with cancer31. More recently this method of 
pain relief has been accepted for patients with HIV/AIDS9 
. 
Outside of Africa studies on attitudes and beliefs about morphine use in a 
palliative setting focus on physicians rather than other cadres of health 
workers32 33.  Elliot and Elliot surveyed over two hundred physicians in North 
America reporting false beliefs and attitudes in the following areas: drug 
efficacy, tolerance and ignorance of the fact that oral morphine is not addictive 
when used in the management of chronic pain34.   A study comparing the 
attitudes of French HIV specialists with oncologists revealed that HIV 
specialists had more restrictive views both about the use of morphine and the 
role of palliative care than did French oncologists35.   
 
Studies from African settings have considered a variety of issues which 
constitute barriers to morphine access.  The WHO five country study 
investigating the provision of palliative care in Botswana, Ethiopia, Tanzania, 
Zimbabwe and Uganda found that pain relief was identified by both patients 
and their family members as a major priority to improve quality of life for those 
with HIV/AIDS and cancer.  That report proposed home based palliative care 
integrated into existing health services as the most practical way to meet needs 
identified in the community. The lack of availability of morphine in the home 
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setting was noted. Ignorance and false beliefs were mentioned as barriers to 
access of appropriate analgesia and other drugs, but these specific issues were 
not investigated in any further detail36.  Since the start of this study a 
comprehensive report on drug availability for palliative care in twelve African 
PEPFAR countries has been published by Kings College, London and the 
African Palliative Care Association37. Thirty six palliative care provider sites 
were asked to respond to a number of questions about the factors affecting the 
availability of pain relieving drugs through completion of questionnaire.  The 
background to the study lists ‘fear of addiction amongst health workers’ as one 
of the global barriers to opiate availability, a factor which was bourne out in the 
reports from palliative care providers.  However it was not within the scope of 
that study to specifically investigate the attitude of health care workers in any 
further detail.  Lack of professional education with resulting prejudice, myths 
and poor prescribing have also been reported to hamper appropriate supply38.  
Reports from APCA regional opioid availability workshops have highlighted 
limited availability of opioid medications, poor knowledge amongst health 
workers and fears of addiction amongst health workers and pharmacists39. 
Logie and Harding in their review of the expanded morphine access 
programme in Uganda highlight the roles nurses, pharmacists and doctors play 
in access to morphine40. Palliative care trained nurses were interviewed; an 
audit of their practise was undertaken as well as a review of the resource 
implications of delivering of oral morphine to distant locations.  Studies from 
other settings echo the key role that nurses play as patient advocates in 
assessment of pain relief41.  The WHO five country study highlights the lack of 
medical staff in many African countries, anticipating that many aspects of 
palliative care will be delivered in the community by both family members and 
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community based volunteers.  As for prescribing, doctors are reported to be the 
main cadre of staff currently allowed to prescribe morphine; though – following 
the Uganda model – the WHO report suggests the possibility of nurses as well 
as care givers being trained in aspects of morphine delivery to improve access 
in the many situations where the numbers of doctors are few.  Such 
considerations are also outlined in other recent WHO papers on the subject.42  
 
The frequent fears of addiction expressed by health workers are not supported 
by evidence in the literature. In a recent letter to the Lancet, Nigel Sykes from 
St Christopher’s Hospice in London calls for physicians to move on from their 
‘opiophobic’ attitudes stating that the risk of iatrogenic addiction is less than 
0.01%43.  Joransen, Ryan, Gilson and Dahl found that despite significant 
increases in the medical use of opiates across the United States between 1990 
and 1996, this did not appear to contribute to any increase in reported opiate 
abuse44.  This is supported by Logie and Harding who reported no cases of 
opiate abuse in over ten years at Hospice Africa, Uganda40.  Glajchen 
highlights how poor understanding of the terms addiction, physical dependence 
and tolerance present barriers optimal opiate prescribing. . In her paper she 
reports that the National Federation of State Medical Boards defines addiction 
as ‘psychological dependence on the use of substances for their psychic 
effects, characterised by compulsive use despite harm’.  This is in contrast with 
physical dependence a phenomenon similar to that found with other long term 
medications e.g. corticosteroids which does occur with opiate medication 45.  
 
There is a general lack of published research on palliative care in Africa 3. 
Review of the literature on health workers beliefs, attitudes and practise on the 
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use of oral morphine highlights papers mainly from outside Africa, focusing 
predominantly on physicians.  Papers from Africa have suggested that false 
beliefs and lack of knowledge amongst a variety of cadres, as well as poor 
reporting systems, hamper access to morphine. With this in mind and in the 
light of the fact that oral preparations of morphine have recently been made 
available for pain relief throughout health institutions in Malawi, it is timely that 
the beliefs, attitudes and practise of frontline health workers in an African 
setting be investigated in order to target interventions which will enhance 
appropriate access to this medication for patients who are in need. 
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Rationale 
 
Pain control is a priority for people living with advanced life threatening 
illnesses.  The World Health Organisation guidelines, shown to be effective for 
pain relief in cancer and HIV/AIDS patients, include the use of oral morphine for 
the relief of severe pain.  Sustained Release (long acting) Morphine (MST) has 
been available in Malawi nationally since 2004 as part of the package of care 
for PLWAs supported by the Global Fund, though expertise in assessing pain, 
prescribing analgesia and follow up is still limited.  Given the scale of the 
HIV/AIDS epidemic in Malawi, and the estimated growth in number of cases of 
cancer, scale up of access to palliative care (including appropriate prescribing 
of morphine) maybe considered a national emergency.  In view of this it is 
critical at this time to assess the beliefs, attitudes and practices of health care 
workers towards the use of oral morphine in HIV/AIDS and cancer patients.  
This can then inform government and other relevant agencies when taking the 
necessary steps to improve access to palliative care including optimal pain 
relief enabling improved quality of life for those most in need.  
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Aim 
 
To investigate the beliefs, attitudes and practices of health care workers 
towards the use of oral morphine for the palliative care management of patients 
with HIV/AIDS and cancer in the Southern Region of Malawi 
 
Objectives 
 
 To describe the beliefs, attitudes and practices of health care workers to 
the use of oral morphine in the palliative care management of HIV/AIDS 
and cancer patients in the Southern Region of  Malawi 
 
 To investigate whether there are differences in beliefs, attitudes and 
practice between clinicians, nurses and pharmacy staff in the Southern 
Region of Malawi to the use of oral morphine  
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Methods 
 
Study design 
This study was a qualitative descriptive study using thematic analysis.   
 
Site 
Interviews were conducted at each of the following types of health care facility 
in the Southern Region of Malawi: 
1. central hospital (larger urban tertiary referral government centre, 465 
beds offering free services to approximately 700 patients per day, staffed by 60 
clinical staff and 117 nurses). 
2.  two district hospitals (smaller local government run hospitals, secondary 
referral centre, 200-300 beds, offering free services to approximately 200 
patients per day, usually staffed by clinical officers or medical assistants and 
nurses) 
3. two CHAM hospitals (smaller local hospitals, 200-250 beds administered 
by a variety of church denominations, offering subsidised cost sharing services 
to approximately 100-150 patients per day, staffed by doctors, clinical officers 
and nurses)  
 
Sampling of study sites 
Study sites were selected by random sampling.  The names of all institutions 
which were listed by the Ministry of Health as being in the Southern region of 
Malawi and which had had MST supplied to them (verified through the Ministry 
of Health ARV supervision team reports) at any time since 2004 were written 
down, folded and put into envelopes.  District hospitals and CHAM facilities 
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were put in separate envelopes and the names of two institutions were selected 
by an independent third party picking the names out of the envelopes. There 
are only two central hospital sites in the Southern region and as one had 
already been visited to conduct the pilot interviews the second one became the 
study site.   
 
 
Participants 
The following cadres of staff were requested to take part in interviews: health 
institution managers (district health officers or district medical officers), clinical 
officer/doctors, nurses, and pharmacy technicians who gave consent to 
participate in this study.  
 
Sampling of participants 
As understaffing is common at many health institutions, convenience sampling 
was used with the aim of selecting one respondent within each cadre at each 
institution.  Health workers were approached as they were met at the institution, 
or else hospital management directed the research assistant to specific 
members of staff who had time to assist in the research.  Any health worker 
who had been qualified for less than two years was excluded, to improve 
uniformity of experience. 
 
Total sample size: 15.  The relatively small sample size reflected the qualitative 
nature of the study, using semi-structured interviews to obtain in depth data 
from each respondent.  
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Data Collection  
 
Data was collected by the use of semi-structured interviews.   
 
Data collection tool 
A semi-structured interview guide was initially drafted by the researcher, 
framing questions to cover issues relating to beliefs, attitudes and practise. 
Demographic data of respondents was included at the beginning to enable 
comparison between different cadres of health care worker.  To improve validity 
of the interview guide it was revised and adjusted after advice and discussion 
with study supervisors. Open questioning with prompts were used to optimise 
quality of data collection whilst ensuring that key points were not missed. To 
improve reliability the interview guide was piloted on three different cadres of 
health care workers at one of the main referral hospitals in Malawi.   It was then 
finally revised based on issues raised during the pilot.  At various times during 
the process of data collection the researcher and research assistant met to 
review progress. 
 
Data collection method 
The interviews were undertaken by a clinical psychologist who is a lecturer in 
the Department of Community Health at the College of Medicine (Malawi’s 
medical school). He is experienced in both qualitative and quantitative research 
methodology and is responsible for training a variety of staff and students in 
research ethics on a regular basis. He is fluent in both English and Chichewa.  
Interviews were conducted in English or Chichewa depending on the 
preference of the participant. Each interview took around thirty minutes to 
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complete.  Content of each interview was recorded and field notes completed at 
the end of each day.  Interviews were transcribed verbatim into English.  Those 
from Chichewa were then back translated by an independent person to ensure 
validity of translation.  Discrepancies were discussed by the research assistant 
and the independent translator and resolved.   
 
Data Analysis 
The researcher read and re-read the interview transcripts to familiarise herself 
with and become immersed in the data. Following this, key themes were 
identified.  Data relevant to these key themes was then reviewed from each of 
the transcripts leading to the development of sub-themes. Ideas for themes and 
sub-themes were shared with supervisors, one of whom did an interim analysis 
of the transcripts, providing comments. Time and budget constraints did not 
allow complete saturation to be reached in data collection, though data analysis 
revealed a number of consistent themes.  Notes from observations were used 
to correlate the data.  
 
Ethical considerations 
 
Ethical approval to conduct the study was obtained from the research ethics 
committee of the University of Cape Town and the College of Medicine 
research ethics committee (COMREC) at the University of Malawi. 
 
All participants were fully informed of the nature of the study, and their 
participation was voluntary.  Permission for participation of staff members at an 
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institution and time off required was sought by letter to the in-charge of the 
institutions involved.  
 
Interviews were conducted in the language of preference of the respondent. All 
the information was collected and was kept in a secure place during field visits.  
Interview data was reviewed only by the research assistant, the researcher and 
project supervisors.  On completion of the study the material will be kept in a 
secure place for seven years and then destroyed.   
 
 
 
 
. 
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Results 
 
Summary of respondents 
 
 Table of respondents 
 
 Job title Profession 
time qualified 
Study site PC 
experience 
 
R1 Hospital manager Clinical officer 
 
Central hospital 
 
none 
R2 Clinician Clinical officer 
> 5 years 
District hospital 
 
Limited 
knowledge of 
PC 
R3 Clinician 
 
Doctor 
2-5 years 
CHAM hospital 
 
none 
R4 Hospital director Doctor 
> 5 years 
CHAM hospital 
 
Some 
exposure 
R5 clinician Clinical officer 
> 5 years 
CHAM hospital 
 
none 
R6 nurse Enrolled nurse 
> 5 years 
District hospital 
 
none 
R7 Hospital manager Registered 
nurse 
> 5 years 
District hospital None 
R8 nurse Registered 
nurse 
District hospital none 
R9 nurse Nurse midwife 
technician 
> 5 years 
CHAM hospital None 
R10 nurse Registered 
nurse 
> 5 years 
CHAM hospital none 
R11 Pharmacy worker Pharmacy 
technician 
Central hospital none 
R12 Pharmacy worker Pharmacy 
technician 
> 5 years 
experience 
District hospital none 
R13 Pharmacy in 
charge 
Pharmacy 
technician 
District hospital None 
R14 Pharmacy worker Pharmacy 
attendant 
2-5 years 
CHAM hospital none 
R15 Pharmacy worker Enrolled nurse 
> 5 years 
CHAM hospital none 
 
No one who was approached refused to give consent and take part in the 
interview process.  
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In total 5 clinicians (2 doctors, 3 clinical officers; of whom 2 were hospital 
managers, 3 were from one institution), 6 nurses (2 registered, 4 enrolled, of 
whom one was a hospital manager) and 4 pharmacy staff (3 pharmacy 
technicians and 1 pharmacy assistant) were interviewed from five institutions: 
three government facilities (one central and two district) and two CHAM 
facilities 
 
Analysis of fifteen semi-structured interviews with health workers from five 
different institutions in the Southern Region of Malawi yielded three main 
themes. The first theme focused around issues relating to the availability of 
morphine, the second theme related to concerns about opiate misuse and the 
third was around education and training needs.  These were further broken 
down into sub-themes as noted in the table below: 
 
Theme one Theme two Theme three 
Availability of oral  
morphine 
Concerns about Opiate 
misuse 
Education and training 
1.1 appropriate use of  
oral morphine 
2.1 misuse amongst 
 Patients 
3.1 need for training of  
health workers 
1.2 use of oral morphine in  
 the community 
2.2 misuse amongst  
health workers 
3.2 need for training of 
community members and 
patients 
1.3 storage, current stock  
and reporting of  
oral morphine 
  
1.4 cost of oral morphine 
 
  
Table of themes and sub-themes developed in data analysis 
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Theme one: Availability of morphine 
 
1.1 Appropriate use of oral morphine 
 
All of the health workers interviewed expressed the belief that oral morphine 
was a drug used in the treatment of pain, particularly for those who were 
chronically or terminally ill.  One clinical officer reported: 
‘as we know those patients who are HIV infected most of the time go through 
severe pain. So they might need it’ (R2). 
A pharmacy assistant said: 
‘oral morphine is good for patients who are in severe pain especially our AIDS 
patients’ (R13). 
 
A number of respondents had a positive experience of using oral morphine to 
help patients in need. As one nurse manager said: 
‘I believe oral morphine is good. I know that morphine works better. If a person 
has severe pain that cannot be relieved by other painkillers, pain that is too 
strong for the patient, morphine does help. I am personally convinced that oral 
morphine is good for the patients’ (R7). 
 
All of those interviewed expressed the belief that oral morphine was appropriate 
for patients with both HIV/AIDS and cancer. As one nurse put it: ‘Many patients 
can benefit from morphine. Those who are benefiting most are cancer patients 
as well as people with AIDS’ (R9).  
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A clinician commented: 
‘.they usually have a lot of pain especially when the cancer is invading some 
nerve endings…so if we make them comfortable it will be good rather than to 
keep them I mean in agony’ (R3).  
Another commented: 
‘AIDS patients are chronic cases…they experience chronic pain and oral 
morphine would assist them to have less pain’(R8). 
 She went on to say: 
‘cancer is one of the chronic conditions and cancer patients are in big pain. 
They can benefit from morphine because usually there is nothing that can be 
done to cure them only to make their life less painful’(R8). 
 
Diarrhoea was the only other reported indication for the use of morphine. ‘Many 
of the patient(s),many of them they have diarrhoea and with the use of 
morphine it may reduce’ (R4). 
 
1.2 Use of oral morphine in the community 
 
Ten respondents discussed whether oral morphine should be available for 
patients in their home setting. Interview findings revealed two sets of attitudes, 
some health workers felt that morphine should be available to people at home 
whilst others expressed reservations about its use in the community.   
 
A clinical officer at a government district hospital said: 
‘when we are discharging the patients we give them oral morphine to take 
home’ (R2).   
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A manager from a district hospital said: 
‘it would be important for the medication to be available to all hospitals 
especially patients who are in severe pain at home’ (R1) 
 
Those who had reservations were mainly concerned about opiate misuse or 
side effects developing without the prescriber’s knowledge. One clinical officer 
expressed his fear that patients may commit suicide: 
‘ if you give them this drug to be kept by them at home my biggest concern is 
maybe they commit suicide because they would see their condition as 
something which is going to be keeping on…my worry would be they may 
commit suicide to ease the pain’ (R5).  
Another reported the need to keep close control over use of oral morphine in 
the community saying: 
 ‘you don’t keep somebody (in hospital) because you want to give them 
morphine…so you say its okay you take these but you don’t give them a 
lot…after a week also you can come by and get some just to control the usage’ 
(R3). 
 
A nurse who had experience of morphine at home reported no problems: 
‘I have administered oral morphine to several patients. Actually I am the HBC 
coordinator and our home based care patients receive morphine.’(R8). 
However the nurse manager from the same institution said: 
‘so far…all the patients I know who were taking morphine, no one was given to 
take home’(R7).  
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
n
 29 
A nurse from a different CHAM facility said: 
‘It (oral morphine) should be available even at their homes, they should be able 
to take the medicine home or even here at the hospital the process of collecting 
it should not be too tedious and difficult’ (R9). 
 
1.3 Storage, current stock and reporting of morphine 
 
Nine of those interviewed were able to clearly express where and how oral 
morphine was kept. They explained the need for trained prescribers and the 
need to follow certain regulations for storage and record keeping according to 
the Dangerous Drugs Act (DDA).  
‘There are people who are trained to prescribe. Those people who were trained 
are the ones to prescribe’(R9). 
 ‘For this hospital not everybody prescribes oral morphine. There are specific 
prescribers.’ (R13). 
 ‘Doctors and some trained clinical officers prescribe. It is kept as a DDA drug 
and its distribution is controlled’.(R1). 
  One pharmacy assistant reported: 
 ‘we have a lockable DDA it’s raised up. It’s always locked and we have got a 
DDA pad whereby we put the name of the patients and the quantity or the 
number of drugs we have dispensed to that particular patient and our balance’ 
(R13). 
 Another pharmacy worker said: 
‘it is only doctors and some trained clinical officers who prescribe. It is one of 
the protected drugs. It is therefore kept as a DDA drug and its distribution is 
controlled.’(R11) 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 30 
 
Others had no experience of the use of oral morphine. These people showed 
poorer reporting of the relevant storage and reporting procedures. One 
pharmacy worker said: 
 ‘I am not going to say anything much because I rarely see it (morphine) used’ 
(R15). 
 At three sites it was reported to be kept in the pharmacy, at one in the 
maternity ward (oral morphine liquid) and at another MST tablets were in the 
ARV clinic. The place of storage seemed to affect availability as one person 
described: 
 ‘we used to get (it) only (in) one place… in (the) ARV(clinic) …and we didn’t 
have access for all the patients like for cancer patients (R4)’. 
 
Although all five of the sites were chosen for interviews on the basis that they 
had at some time had oral morphine (MST tablets) available, at only two of the 
institutions did interviewees report availability at the time of the interviews.  A 
pharmacist from a government central hospital reported: 
 ‘sometimes it’s there but sometimes it is not available like right now we don’t 
have it’ (R11).   
The nurse assisting in pharmacy at a CHAM facility said: 
 ‘now we don’t have the drug’ (R15). 
 Another pharmacy attendant said: 
 ‘it seems we don’t have (morphine) at the moment, but some patients come 
looking for it’(R14) 
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At one institution there was some inconsistency in reporting.  One pharmacist 
said: 
 ‘it’s not used here. In fact it is not available (R12)’. 
A clinician from the same site on the same day reported: 
 ‘I have not come across a situation where I prescribe morphine and it is not 
available…since I came here I have not met the problem of morphine 
availability’ (R2). 
 
Many respondents expressed the desire for improved availability of oral 
morphine, a pharmacy worker who reported frequent experience of dispensing 
morphine said: 
 ‘my comment is the government should make sure this drug is always 
available at regional medical stores’ (R13). 
 These sentiments were echoed in the comments of one clinician who said: 
‘you should try to make sure that this drug is readily available since this time we 
have a lot of cases of HIV/AIDS and cancer patients. It will be an advantage to 
those patients to have these drugs’(R2). 
 
 
1.4 cost of oral morphine 
 
A variety of health workers expressed the belief that morphine is an expensive 
drug and that this would affect its availability.  One reported: 
 ‘it is expensive thus why sometimes it might not be available in the hospitals’ 
(R13),  
another said: 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 32 
 ‘I have never seen its price but I have heard that it is expensive’ (R5). 
In practise a number of respondents explained that their institution had received 
morphine free of charge as part of the package of drugs funded by the Global 
fund: 
 ‘since we had it for free I may not be a hundred per cent right to say it is 
expensive while it is not’ (R5).  
 
Theme two : concerns about opiate misuse 
 
2.1 Misuse amongst patients 
 
 A range of respondents believed that the medical use of oral morphine would 
cause the problem of addiction, and also felt that this was a widely held and 
legitimate view.  A clinician (also a hospital manager) said: 
 ‘the general thinking (is) that probably he is going to become addicted’ (R4). A 
pharmacy assistant said: 
 ‘if it is prescribed anyhow, then many young patients would be addicted’ (R12).   
This belief also affected the attitudes and practise towards prescribing so that 
one nurse reported only prescribing for a short period: 
 ‘maybe it (addiction) could be a problem but because the patients we give 
morphine to are not given to take it for a long period.  Sometimes its just seven 
days and its difficult to get addicted in that short period’ (R7).  
Another clinician reported prescribing at a late stage: 
 ‘most of my patient(s) when I start morphine I know that the chance of them 
being addicted is low because some of them are terminal…even if they came 
addicted when they are about to die it’s ok’(R3).  
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One clinician was only confident to prescribe up to a certain dose: 
 ‘I may not feel comfortable to go beyond 30mg or something higher…the 
biggest concern would be morphine is a narcotic so if a patient get(s) a higher 
dose she might be addicted earlier than expected’ (R5).  
 
2.2 misuse amongst health workers 
 
This fear was expressed by several of the interviewees. One pharmacy 
assistant said: 
 ‘the fear is sometimes it starts from the hospital, the staff, they really abuse it 
sometimes;’ (R6) 
though when asked more about any experience of problems related to 
addiction he said: 
 ‘I haven’t experienced any. Either from the hospital or the prescribers I haven’t 
heard any’ (R6).  
A clinician said ‘there are some health workers they feel good when they take 
it…so the fear is abuse’ (R3). 
 
Not all shared this view, as one nurse reported: 
 ‘I have never heard or seen that a health worker has abused morphine. Even 
when some has been kept in the ward for particular patients, there has never 
been an incident when the drug went missing’ (R7). 
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Theme 3 : education and training 
 
3.1  Need for training of health workers 
 
3.1.1 Poor understanding of side effects 
 
Though knowledge was not formally assessed in this study, all respondents 
were asked to give their comments on side effects which patients might 
experience when given oral morphine. 
 
Of the fifteen interviewed most of the clinicians and one nurse reported 
constipation as a side effect: 
. ‘the main side effect is constipation…so we usually prescribe a laxative as 
well’ (R3).  
Other respondents reported they did not know of any side effects: 
 ‘I don’t know of any side effects’ (R7)  
or else reported the following as possible side effects: respiratory depression, 
vomiting, weakness and severe headache.  
‘I have heard that when a patient receives morphine he will feel severe 
headache’ (N15)    
One elderly nurse working in the pharmacy at a CHAM facility said: 
 ‘it’s a bad drug it can kill and even its side effect(s) are very dangerous’ (R15) 
though she did not mention anything specific. She had only ever dispensed 
sixty tablets (one month’s supply) of morphine during her time working in the 
pharmacy.  None of the other respondents expressed similar views to this.  
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3.1.2  Confusion with pethidine 
 
Both when discussing pain relief and the problems of addiction, there was 
some evidence of confusion between pethidine and oral morphine. One 
clinician’s report of addiction amongst health workers: 
 ‘he or she says its only going to work if you give me morphine so next time 
they come and you give them (an) injection which they think its pethidine they 
feel good so that is the issue’(R3). 
 Despite being asked about their concerns of oral morphine tablets or solution a 
nurse reported: 
 ‘I know several workers who are addicted; one is addicted to pethidine and the 
other valium’(R8) 
One retired nurse who was doing locum work looked completely blank when 
asked what oral morphine was, she then asked if it was the same as pethidine 
(R6).  
 
3.1.3 Expressed need for training 
 
Clinicians interviewed expressed the need for further training of health workers. 
One said: 
 ‘I feel it would be helpful if you gave us maybe some form of a talk or a course 
on what type of patients we should prescribe morphine (for). Each clinician here 
prescribes based on personal judgement’ (R2).  
Another said: 
 ‘most of the people do not get trained, especially when they are doing palliative 
care’ (R5).  
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A hospital manager said: 
 ‘…training and teaching people how to use it and when to use it I think that 
way it is going to help the patients’,  
he finished by saying: 
 ‘we are inexperienced and need a lot of experience in the use of morphine in 
our patients’ (R4).  
 
3.2  Need for training of community members and patients 
 
This was mentioned by a number of respondents, either as formal training or as 
the need for information giving whilst dispensing oral morphine. A nurse said: 
 ‘it will just be necessary to tell the patients to be more careful since its one of 
the dangerous drugs. So tell them not to give to any other person apart from 
themselves’ (R9).   
A hospital manager said: 
 ‘they need to come (and) teach the family or the guardian how really to look at 
the side effect(s)’(R4). 
 
On the need for training community home based care volunteers on oral 
morphine one clinician said: 
 ‘I may not be comfortable (to allow morphine to be used at home) because 
some of those may not be trained on the drugs so a drug like morphine I don’t 
think I might be comfortable to let it go to the home based patients’ (R5). 
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Discussion 
Effective pain relief has been identified by patients and their families as a main 
priority to improve their quality of life9, and this priority is central to the definition 
of palliative care. Oral morphine is recommended by the WHO as ‘the drug of 
choice for severe pain in cancer’30 and has more recently been recommended 
for pain relief in patients with HIV/AIDS9.  A number of barriers to the effective 
delivery of morphine exist, amongst which the beliefs, attitudes and practises of 
health workers have previously been suggested to be significant.    
 
Other studies have employed interviews with specific cadres of staff (e.g. 
nurses) already working or trained specifically in palliative care. This is the first 
study to conduct face to face interviews with different cadres of African health 
care workers to assess their beliefs, attitudes and practises regarding the use 
of oral morphine in HIV/AIDS and cancer patients. Care for patients with 
HIV/AIDS and cancer forms much of the daily workload at government and 
CHAM facilities in Malawi. In the light of the severe shortage of human resource 
in Malawi, the respondents represent cadres who are going to make a 
difference as to whether or not oral morphine medication is safely and 
appropriately prescribed for those with HIV/AIDS and cancer presenting to 
health services.  It was important that all cadres were interviewed, since it is not 
only prescribing, but also dispensing and administration that may present 
barriers to patients’ access40.  Clinical practise at my own institution has shown 
how pharmacy workers play a key role in the supply chain. Pharmacies have a 
heavy workload and are understaffed. As a controlled drug, oral morphine must 
be correctly dispensed and recorded each time it is prescribed.  On occasions 
patients have been sent back with the report that oral morphine is out of stock, 
only to find it was available when they were subsequently accompanied by one 
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of our team members.  This situation improved after a sensitisation meeting for 
pharmacy staff on palliative care and the use of oral morphine (and other 
medications) for pain and symptom control.  This example is echoed by Logie 
and Harding in Uganda who found that experienced palliative care ‘nurses felt 
that having a pharmacist with a positive attitude to morphine use was key to 
obtaining uninterrupted supplies’ 40 
 
Three main themes were identified in the results.  Firstly health workers 
highlighted appropriate use, use in the community, storage, reporting and cost 
of oral morphine. 
 
Most knew about the primary indication of morphine in the treatment of severe 
pain, and were equally confident about its use for patients with either HIV/AIDS, 
cancer or both.  As Kaposi’s sarcoma – an AIDS related cancer - is the 
commonest cancer seen in clinical practise in Malawi46 this is perhaps not 
surprising, also given the fact that HIV/AIDS and cancer services are not 
delivered by specialists in Malawi but are part of general medical care. This 
contrasts with a study from more specialised services in France which found 
that HIV clinicians and oncologists differ in their attitudes to the use of morphine 
and palliative care35.  
 
Some clinicians and nurses expressed concerns about where morphine should 
be available, specifically whether it was safe to give to patients to take at home. 
Concerns focused around the possibility of addiction, developing side effects or 
even committing suicide without appropriate backup.  One district hospital 
where staff reported regular use of morphine both at hospital and at home 
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expressed no such doubts, suggesting that some fears maybe fuelled by lack of 
experience.  
 
The Uganda model of public health expansion to improve access to morphine 
has shown that oral morphine can be safely and effectively delivered at 
community level40.  Learning from this experience is critical considering that the 
vast majority of the population of Malawi live in rural areas, often far away from 
their nearest health facility. In my experience of six years doing HIV palliative 
care at a government central teaching hospital in Malawi many patients present 
with already advanced disease. Mobility and/or money for necessary transport 
to hospital already limits access to care, and repeated visits to hospital are 
difficult or impossible. Once pain has been controlled patients must to be able 
to travel home with adequate supplies of oral morphine (and/or other 
medications).  Out-patient follow up should ideally be situated as near as 
possible to their home setting for holistic symptom review, administration of 
necessary medications and other interventions. Provision should also be made 
for adequate pain assessment and effective pain control to begin in the home 
setting for those unable to reach the health facility. It is vital that health workers 
have both experience with and confidence in the safe use of morphine in the 
home setting in order to develop the ‘low cost, high coverage approach’ 
recommended by the WHO five country study9. 
 
In 2006, the Malawi delegation at the APCA Regional Advocacy workshop for 
Palliative Care in Africa identified poor data collection and reporting systems by 
health facilities and stock outs of essential drugs as problems to be addressed 
as part of a national pain medication advocacy strategy. This study revealed 
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that a third of those interviewed were unable to supply information on the 
correct practises for storage and reporting of morphine at their facility.  Poor 
knowledge of reporting corresponded to study sites where oral morphine was  
not available and/or respondents who had a lack of experience of morphine 
use.  Only two hospitals reported that MST was available at the time the 
interviews were conducted, although the health facilities visited were chosen on 
the basis that they have had morphine sulphate tablets supplied at some time 
since 2004.  Review of the quarterly reports from the Ministry of Health 
supervision teams confirmed the reported stock outs revealing that one study 
site last had MST in stock in the first quarter of 2006, whilst another had 
recorded very limited stock (less than 100 tablets) since the end of the second 
quarter of that year (Professor Tony Harries, personal communication). Stock 
outs of all pain relief medication recommended in the WHO analgesic ladder 
(including adjuvant analgesia) was a common finding in the Kings 
College/APCA report on pain relief availability in twelve African PEPFAR 
countries37.  
 
In this study there was also a lack of consistency in reported availability at one 
study site where the pharmacy worker reported that there was no morphine 
available, whereas the clinician reported ‘no problem’ with morphine availability.  
This may reflect the lack of consistent policies and guidelines regarding 
opiates, or the fact that the clinician never prescribed morphine (hence there 
was ‘no problem’!). The pharmacist from another study site reported a regular 
(daily) practise of reporting on drug availability (including morphine) to senior 
staff, and there was a notable confidence in prescribing attitude from all who 
were interviewed at this facility. The MOH quarterly reports show progressive 
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steady decrease in stock of MST at this institution between mid 2005 and the 
third quarter of 2007 (the last available report) which is consistent with their 
reported experience in prescribing, administration and dispensing of MST .  
Interview data from this study site may also have been influenced by the fact 
that both the nurses interviewed were registered nurses (two of only three 
registered nurse respondents in the study),  and the pharmacy technician was 
in an older age bracket (therefore possibly more experienced) than the 
pharmacy staff from other study sites.  
 
Cost was mentioned by some respondents, and this has also been raised as a 
concern to the researcher by medical students during palliative care teaching 
sessions.  Careful consideration of the use of limited resources for health care 
is a key concern in Malawi.  If health workers believe that oral morphine is 
expensive they may be less willing to use it. Though not yet widely available in 
Malawi, oral morphine liquid is the cheapest formulation of morphine 
available47.  Senior staff from Hospice Africa Uganda have reported that they 
can treat a patient with oral morphine liquid for two weeks for the same cost as 
a price of a loaf of bread (Dr Anne Merriman, personal communication).  At a 
national advocacy workshop hosted by the Palliative Care Association of 
Malawi and the Ministry of Health in February 2008 it was recommended that 
both oral morphine liquid and morphine tablets should be available at all health 
institutions in Malawi.  Morphine slow release tablets are considerably more 
expensive than morphine liquid. They are procured through Global Fund 
procedures.  Both tablet and liquid formulations of morphine are listed in the 
Essential Health Package medicine and supplies list for Malawi 25.  
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Concerns about opiate misuse have been widely reported in previous studies 
as a belief amongst health workers 36-40,43,45. This presents a huge barrier to 
patients accessing oral morphine.  In this study two groups were considered by 
respondents to be at risk of opiate abuse, firstly patients and secondly health 
workers. The majority of respondents expressed concerns about addiction in 
either or both of these groups. Those reporting frequent experience of 
prescribing morphine were less likely to express the attitude that patients were 
at risk of addiction. None of those interviewed were able to report or recall any 
actual cases of addiction to oral morphine to support their fears.  This is 
reflected in the literature which reports negligible or no opiate abuse or 
diversion when opiates are made available for palliative care patients followed 
up in both African and other settings10, 39, 43, 44 48.   
 
Concerns about addiction directly impacted on both prescribing practise and 
administration of morphine. Respondents suggested that either reducing the 
dosage or the duration of oral morphine may reduce the risk of addiction. One 
clinician suggested that morphine may be started when the patient didn’t have 
long to live at which stage the risk of addiction would be less of a concern. 
Such beliefs severely limit efficacious analgesic prescribing; 
‘Strong opioids exist to be given, not merely to be withheld; their use should be 
dictated by therapeutic need and response, not by brevity of prognosis.’49  At 
the heart of the WHO definition of palliative care is the stated aim to prevent 
and relieve suffering by ‘the early identification and impeccable assessment of 
pain and other symptoms…’7.  Malawi has no government funded adult 
oncology services (either for chemotherapy or radiotherapy), and the mainstay 
of management for patients with cancer from the time of diagnosis requires a 
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palliative approach with optimal pain and symptom control.  Pain relief in 
patients with HIV/AIDS is often underdiagnosed and treated50. According to the 
WHO analgesic ladder medication should be given ‘by mouth, by the clock and 
by the ladder’ with dose titration upwards until pain is adequately controlled51.  
Between January and December 2006 fifty one percent of two hundred and 
twenty eight patients referred to our HIV palliative care service received oral 
morphine to control pain or other symptoms52.  Physical dependence to opiates 
may occur (i.e. the necessity for continued use of morphine to control 
symptoms) but this is true of other medications (e.g. antihypertensives). Such 
dependence should not be confused with the psychological craving which 
characterizes addiction.  
 
The WHO public health strategy for palliative care emphasises that education 
at all levels is required to scale up a national palliative care response47. 
Respondents expressed the belief that training was required, both for health 
workers and for patients, their carers and community members.  Mostly this 
training was believed to be required to optimise the safe use of opiates, though 
improving knowledge at community level may also increase appropriate 
demand for medication.  
   
Only three of the respondents reported ‘some’ or ‘limited’ experience of 
palliative care, whilst the rest reported no experience of palliative care when 
demographic information was being collated.  Although progress has been 
made in establishing a five day introductory course in palliative care for health 
workers, there is clearly a need to scale up training, both through this course 
and also though inclusion of an evidenced based palliative care component in 
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pre-service training curricular. The need to improve the breadth and depth of 
palliative care training for HIV/AIDS care providers was recommended by the 
Kings College/APCA research collaborative following their assessment of pain 
relief across twelve countries in Africa37.   
 
All the facilities visited were known to have had MST available for the control of 
severe chronic pain, though high turnover of staff may explain why some of the 
respondents reported no experience in the use of oral morphine. Knowledge 
about side effects of morphine were patchy and generally poor, particularly 
amongst nurses and pharmacy workers. Some were incorrect (e.g. severe 
headache). On a number of occasions beliefs about morphine and pethidine 
were expressed interchangeably. When asked about fears of using oral 
morphine a number of respondents expressed concerns about addiction to 
pethidine.  A report prepared by the Pain and Policy Studies Group for the 
APCA Regional Advocacy workshop for Palliative care in Africa mentions that 
pethidine is still widely used despite the fact that it is no longer recommended28. 
 
Training on issues relating to palliative care at community level in Malawi have 
largely been delivered through home based care programmes monitored by the 
Nursing Section at the Ministry of Health. National policies and guidelines for 
home based care in Malawi have been in place since 2005, and home based 
care forms one of eleven components of the Essential Health Package outlined 
in the Joint Programme of Work for 2004-2010 by the Ministry of Health25.  
Review of the home based care policy document reveals mention of the need 
for ‘palliative care including psychosocial and spiritual care’ but does not 
specifically emphasise the need for adequate pain relief as part of the package 
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of services for community care53. Only step one analgesics (of the WHO three 
step analgesic ladder30) - paracetamol, aspirin and diclofenac, are listed for 
inclusion in the home based care supervisor’s kit. This reflects the fact that 
much of the development of home based care training, provision and 
supervision in Malawi was led by health workers unfamiliar with the definition of 
palliative care, including the requirement for adequate pain and symptom 
control. This is changing. Senior pharmacy, nursing and clinical representation 
on the Malawi delegation to the APCA Regional Drug Availability Workshop, 
has been followed up by advocacy by the Palliative Care Association of Malawi. 
Senior nursing staff from the Ministry of Health are also enrolled on distance 
learning courses such as the Distance Learning Diploma offered by Hospice 
Africa Uganda.  
 
Review of community based services in other African countries also highlighted 
the problem of limited access to oral morphine through home based care 
programmes.  The executive summary of the WHO five country study states 
‘one of the major hindrances to the provision of palliative care in this region is 
the problem of access to medicines, especially opiates for the relief of pain9’.   
This report recommends the development of suitable training for community 
members and family caregivers to optimise outcomes.   The need to expand 
home based care training to incorporate suitable training on pain and symptom 
control has been accepted by the Ministry of Health in Malawi and it is working 
in collaboration with the Palliative Care Association of Malawi in order to 
achieve this.  
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The second objective of the study sought to establish whether there were any 
differences seen between the different cadres? The sample size was too small 
to clearly determine differences, however all respondents expressed concerns 
about the possibility of addiction. Pharmacy staff were less likely to raise 
concerns about the use of morphine in the community. They were less able 
than clinicians to report the common side effects of oral morphine.  Only one 
nurse correctly reported the side effects of oral morphine. Clinicians more 
commonly expressed the attitude that there was a need for training of health 
workers as well as patients, family members and the community.  Those (from 
any cadre) who reported experience in using oral morphine generally 
expressed a more positive attitude to its use and the need for its greater 
availability.   
 
Limitations of the study 
During this study the identification of respondents was not easy. Unreliable 
infrastructure hampered planning: Study sites could not be reached by phone, 
only one of the facilities had access to e-mail and postal services are 
unreliable. Travel to the study sites was sometimes difficult especially as it was 
the rainy season. Such challenges to undertaking research in Africa have 
previously been recognised54.  Added to this – and despite repeat visits - a 
general shortage of health workers meant that it was often difficult to identify 
staff available for interview once we were at the study site and had gained 
permission from hospital management.  Out of fifteen respondents only eight 
were at a professional grade (i.e. clinical officer, doctor or registered nurse 
level), which reflects the reality of the human resource situation in the country.   
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It was also noted that the quality of interview data recorded improved as the 
study proceeded despite conducting pilot interviews. The research assistant 
was very experienced in qualitative research methodology but was not 
conversant with issues relating to the use of oral morphine. He raised concerns 
about morphine addiction during the briefing before the start of the interviews 
but as time went on he learnt more about oral morphine and explored issues 
raised in more detail.  He commented at the end of the study that he had 
enjoyed learning more about palliative care and the use of oral morphine during 
the course of his involvement with the study.  It was necessary to use an 
independent research assistant so as not to bias the comments of respondents 
who may have tried to please the researcher who is known to be involved in 
palliative care. The researcher travelled with the research assistant to the study 
sites but did not take part during the interviews. 
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Conclusion 
 
This study investigates the beliefs, attitudes and practises of a variety of cadres 
of health workers towards the use of oral morphine in the palliative care 
management of patients with HIV/AIDS and cancer in the southern region of 
Malawi. Previous literature has suggested that health workers fear addiction, 
lack training and are not conversant with adequate reporting systems when 
using oral morphine. These suggestions are supported by the findings of this 
study.   
 
All of the respondents understood that morphine was a pain relieving drug, and 
expressed the belief that it should be more widely available for patients with 
both HIV/AIDS and cancer related problems. However, other beliefs, attitudes 
and practises present major barriers to timely access to oral morphine for the 
treatment of pain.  
 
Despite the fact that wider medical availability of opiates has not been found to 
significantly influence opiate addiction44, there was widespread fear that 
patients and/or health workers may become addicted to oral morphine.  No 
respondents had any evidence to support this fear.  Fears of oral morphine 
addiction were confounded by confusion between oral morphine and pethidine 
(which is no longer recommended for the control of chronic pain).  Fears led to 
attitudes seeking to restrict oral morphine use in the community and to poor 
prescribing practise.  Respondents believed that either short prescriptions or 
limiting the dose prescribed could reduce the risk of addiction. Such practises 
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are at odds with standard teaching in the assessment and management of pain 
taught in palliative care49.  
 
A third of respondents were unable to clearly describe the proper storage and 
reporting practises required when prescribing oral morphine, a finding 
exacerbated by lack of experience in handling oral morphine. Stock outs of oral 
morphine were reported (and confirmed by Ministry of Health reports) at three 
of the five study sites.  Respondents also identified the need for training of 
health workers, patients, family and community members. Owing to the small 
sample size it was not possible to determine differences in the beliefs, attitudes 
and practises of the different cadres of respondents.  
 
 
Recommendations 
 
Timely response to the issues raised in this study is required if the long term 
needs of patients and their families affected by HIV/AIDS and cancer are to be 
met. Palliative care aims to improve the quality of life for such patients and their 
families and the use of oral morphine to control severe pain is integral to this.  
 
At an international level support is required for the ongoing advocacy work of 
organisations such as the Pain and Policy studies group of the University of 
Wisconsin and the African Palliative Care Association.  The appointment of 
Pain Policy fellows for Africa is key to this process, as they aim to improve the 
availability of opiate analgesics for pain management. 
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Education is required to inform the practise of prescribing, administration and 
dispensing of oral morphine. It should cover issues of pain assessment and 
management, as well as tackling strongly held beliefs about of the risk of 
addiction to oral morphine.  To ensure coverage, palliative care modules should 
be integrated into the curriculae of all pre-service training institutions for health 
care workers as well as into existing home based care training curriculae for 
community care providers. Established palliative care services should offer 
attachments to health workers, providing experience in the practical handling of 
oral morphine. 
 
Education and training should be linked to the development of appropriate 
guidelines and policies on issues relating to palliative care and the use of oral 
morphine. Policy implementation should be monitored and evaluated.  At 
institutional level clear protocols should be established for the use of oral 
morphine (including assessment, prescribing and reporting) reflecting current 
national clinical guidelines and legislation. All new and existing staff should be 
briefed on these protocols.  
 
A country-wide assessment of the knowledge, attitudes, beliefs and practise of 
health workers and managers of health institutions should be undertaken to 
target appropriate interventions to each cadre. More objective tools should be 
developed for assessing the practise of health care workers to assist with a 
rigorous country-wide assessment.  Undertaking a situational analysis of 
palliative care needs in Malawi will help to guide the Ministry of Health, working 
in partnership with the Palliative Care Association of Malawi and other key 
stakeholders, as develops an appropriate response. 
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Appendix 1 
 
Title of study: An investigation of the beliefs, attitudes and practise 
of health care workers towards the use of oral morphine in the 
palliative care management of patients in Malawi 
 
 
 
Information for managers of institutions in which interviews will take place 
 
Thank you for taking time to read this important information. Please ask for 
further information should you have any questions. 
 
Health care workers (clinical officers, doctors, nurses and pharmacy workers) 
from your institution are being requested to be interviewed on the subject of 
use of oral morphine for HIV/AIDS and cancer patients in Malawi. The 
research is investigating the attitudes, beliefs and practises of health workers 
in Malawi towards the use of oral morphine in HIV/AIDS and cancer patients.  
 
The research project involves a single interview per participant. It is estimated 
that the interview will take 30 minutes to complete. There will be no further 
requirements after this has taken place.  No financial cost will be involved. All 
information is treated as confidential and any reporting will be made 
anonymous.  
 
The results will be analysed and presented to gatherings of health 
professionals, but no individual taking part in this project will be identifiable 
from the results. Please let the researcher know if you are interested to 
receive information about the findings of this research. 
 
 
Many thanks 
 
Yours faithfully, 
 
 
 
 
Dr M Jane Bates 
Principle Investigator 
 
(For M Phil Palliative Medicine, University of Cape Town) 
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I _______________________________(please print your name) 
 
 
Of 
 
 
________________________________  
 
(please write name of your institution) 
 
 
Confirm that I have read and understand the information above. 
 
I agree that this site may be used as a study centre for this research project 
 
 
 
Signed __________________________ 
 
Date ____________________________ 
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Appendix 2 
 
Title of study: An investigation of the beliefs, attitudes and practise 
of health care workers towards the use of oral morphine in the 
palliative care management of HIV/AIDS and cancer patients in 
Malawi 
 
INFORMATION FOR PARTICIPANTS 
 
You are being asked to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully. Talk 
to others about the study is you wish.  After reading the following information, 
please feel free to ask anything to be explained that you do not clearly 
understand. 
 
Purpose of the study 
The purpose of the study is to investigate the beliefs, attitudes and practise of 
variety of health care workers towards the use of oral morphine in HIV/AIDS 
and cancer patients in Malawi.  
 
Why have I been chosen? 
You have been chosen as a category of health worker at your institution. 
Institutions in the Southern region of Malawi have been selected on the basis 
of oral morphine availability.  At each institution the following cadres of health 
workers are being asked to participate in an interview which will record their 
beliefs, attitudes and practise of oral morphine use. Cadres include nurses, 
pharmacy workers, clinical staff (either clinical officers or doctors) and hospital 
managers. 
 
Do I have to take part? 
No. It is up to you to decide whether or not you want to take part. If you do, 
you will be given this information sheet to keep and asked to sign a consent 
form.  You are free to withdraw at any time and without giving a reason. 
 
What will happen to me if I agree to take part? 
You will be interviewed by an independent researcher at your work place. 
Interviews will last 30 minutes. With your consent the interview will be tape 
recorded and transcribed verbatim (i.e. written out word for word) in order to 
enable a detailed qualitative analysis. Verbatim quotation will be used in 
publications but will be anonymised so that participants will not be identifiable. 
The content of the interviews will inform the design of a larger survey in a 
subsequent research phase. 
 
Expenses and payments 
No financial cost will be involved, and no payment will be made for taking part 
in this research. 
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Further information 
Further information about this study can be received from the research project 
lead Dr Jane Bates under the contact details provided below.  These details 
can also be used to raise any concerns during the study. 
 
This research study has been developed taking into consideration the 
requirements of the Helsinki Declaration. 
 
 
 
Dr M Jane Bates 
Department of Medicine 
College of Medicine 
P/Bag 360 
Chichiri, Blantyre 3 
Malawi 
 
Tel : 01870202 
 
 
UCT Research Ethics Committee: 
Faculty of Health Sciences 
Research Ethics Committee 
E52- 23 Old Main Building, Groote Schuur Hospital, Observatory ,7925 
Tel: 27 21 4066492 Fax: 27 21 4066411 
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Appendix 3 
CONSENT FORM 
 
Title of study:  An investigation of the beliefs, attitudes and 
practise of health care workers towards the use of oral morphine in 
the palliative care management of HIV/AIDS and cancer patients in 
Malawi 
 
 
  Please initial box 
1 I confirm that I have read and understand the 
information sheet for participants. I have had 
the opportunity to consider the information, ask 
questions and have had these answered 
satisfactorily in a language I understand 
 
 
2 I understand that my participation is voluntary 
and that I am free to withdraw at any time, 
without giving any reason, without my work, 
career or legal rights being affected 
 
 
3 I consent that the interview is tape recorded 
and transcribed word for word with the 
possible use of word for word – but fully 
anonymised – quotation in reports and 
publications 
 
 
4 I consent that the demographic data provided 
may be used to analyse the qualitative data 
from the interview but won’t be used to identify 
me as a participant in this study 
 
 
5 I agree to take part in the above study 
 
 
 
 
______________________ ___________ ___________________ 
Name of participant   date   signature 
 
______________________ ___________ ___________________ 
Research assistant   date   signature 
 
 
 
study number _____/______ 
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Appendix 4 
Interview framework for the investigation of the knowledge, beliefs, attitudes 
of health care workers towards the use of oral morphine in HIV/AIDS and 
cancer patients in Malawi 
 
Interviewer initials ___________ 
 
Date of interview conducted __ /__ / 07 
 
Place of interview ____________ 
______________________________________________________________ 
Interviewee details (complete/circle as appropriate) 
 
Job title  ______________________ 
 
Place of work ______________________ CHAM  Central District 
 
Age   <30   30-45  45-60  over 60 
 
Number of years qualified  <2  (exclude)  2-5 years >5 years 
 
Sex   M F 
 
Nationality Malawian Other ____________________ 
 
Highest professional qualification 
 
MBChB (or equivalent) Dip Clinical Medicine (or equivalent) 
 
Community enrolled nurse  Enrolled nurse Registered nurse 
 
Pharmacy technician 
 
Other (please state)_________________________________ 
 
Palliative care experience 
 
a) None   
 
b) limited knowledge (e.g. lunchtime meeting or other) 
 
c) member of palliative care team  
 
d) completed 5-day training in palliative care 
 
e) completed higher qualification in palliative care 
 
f) other (please state) ____________________________________ 
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Semi-structured interview guide 
 
 
Tell me about the use of oral morphine at your institution. 
(to include who prescribes, how drugs are stored, what procedures are 
followed in the reporting of morphine use) 
    
 
 
Have you ever prescribed/dispensed/administered oral morphine (either MST 
tablets or oral morphine solution) for a patient? 
  
 
 
  
Which patients might benefit from oral morphine? 
 
 
 
Do you think morphine is a useful drug for patients with HIV/AIDS in Malawi?
   
 
 
Do you think morphine is a useful drug for patients with cancer in Malawi?   
 
 
  
What are the side effects that patients might experience when taking these 
medications 
 
 
 
Do you feel confident in prescribing/dispensing/administering oral morphine to 
patients with HIV/AIDS?  
 
 
 
Do you feel confident in prescribing/dispensing/administering oral morphine to 
patients with cancer?  
 
 
 
Do you feel confident in prescribing/dispensing/administering oral morphine to 
patients with other conditions?  
 
 
  
study number _____/______ 
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Do you think oral morphine tablets and/or liquid should be more readily 
available to your patients?  
 
 
Why or why not? 
 
 
 
 
 
  
What concerns or fears do you have about the use of oral morphine tablets or 
solution in HIV/AIDS and cancer patients?  
 
 
 
(If not mentioned should specifically ask ‘Do you think it is an expensive 
drug?’ and ‘what about addiction’)) 
 
 
 
Do you have any other comments you would like to make relating to the use 
of oral morphine in HIV/AIDS and cancer patients in Malawi?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part in this research project 
 
 
 
 
 
 
 
 
 
study number _____/______ 
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